Regeneron Pharmaceuticals, Inc. United States of America (USA)

Research

Date range: 1 June 2021 - 31 May 2022

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Regeneron Pharmaceuticals, Inc. published between 1 June 2021 - 31 May 2022 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Regeneron Pharmaceuticals, Inc.
Count Share
32 13.09

Outputs by subject (Share)

Outputs by subject
Subject Count Share
28 9.09
4 4.00
1 0.20

Share output for the past 5 years

Share per year
2017 2018 2019 2020 2021
4.95 8.00 5.35 13.98 12.51

Compare Regeneron Pharmaceuticals, Inc. with other institutions

Collaboration

Date range: 1 June 2021 - 31 May 2022

International vs. domestic collaboration by Share

  • 50.13% Domestic
  • 49.87% International

Hover over the graph to view the percentage of collaboration.


Top 10 domestic collaborators with Regeneron Pharmaceuticals, Inc. by Share (145 total)

  1. Regeneron Pharmaceuticals, Inc. and Geisinger Health System (GHS) (3.87)
    Regeneron Pharmaceuticals, Inc.3.36
    Geisinger Health System (GHS)0.51
  2. Regeneron Pharmaceuticals, Inc. and University of Pennsylvania (Penn) (3.85)
    Regeneron Pharmaceuticals, Inc.3.43
    University of Pennsylvania (Penn)0.42
  3. Regeneron Pharmaceuticals, Inc. and Harvard University (2.92)
    Regeneron Pharmaceuticals, Inc.2.45
    Harvard University0.47
  4. Regeneron Pharmaceuticals, Inc. and National Institutes of Health (NIH) (1.89)
    Regeneron Pharmaceuticals, Inc.1.05
    National Institutes of Health (NIH)0.84
  5. Regeneron Pharmaceuticals, Inc. and Broad Institute of MIT and Harvard (1.82)
    Regeneron Pharmaceuticals, Inc.1.57
    Broad Institute of MIT and Harvard0.24
  6. Regeneron Pharmaceuticals, Inc. and Massachusetts Institute of Technology (MIT) (1.69)
    Regeneron Pharmaceuticals, Inc.1.57
    Massachusetts Institute of Technology (MIT)0.12
  7. Regeneron Pharmaceuticals, Inc. and Stanford University (1.68)
    Regeneron Pharmaceuticals, Inc.1.13
    Stanford University0.54
  8. Regeneron Pharmaceuticals, Inc. and U.S. Department of Veterans Affairs (1.63)
    Regeneron Pharmaceuticals, Inc.1.51
    U.S. Department of Veterans Affairs0.11
  9. Regeneron Pharmaceuticals, Inc. and University of Southern California (USC) (1.29)
    Regeneron Pharmaceuticals, Inc.1.05
    University of Southern California (USC)0.24
  10. Regeneron Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc. (1.19)
    Regeneron Pharmaceuticals, Inc.1.06
    Alnylam Pharmaceuticals, Inc.0.13

Top 10 international collaborators with Regeneron Pharmaceuticals, Inc. by Share (507 total)

  1. Regeneron Pharmaceuticals, Inc. and Lund University (LU) (1.87)
    Regeneron Pharmaceuticals, Inc.1.45
    Lund University (LU)0.43
  2. Regeneron Pharmaceuticals, Inc. and Karolinska Institute (KI) (1.69)
    Regeneron Pharmaceuticals, Inc.0.82
    Karolinska Institute (KI)0.87
  3. Regeneron Pharmaceuticals, Inc. and Institute for Molecular Medicine Finland (FIMM) (1.57)
    Regeneron Pharmaceuticals, Inc.1.46
    Institute for Molecular Medicine Finland (FIMM)0.11
  4. Regeneron Pharmaceuticals, Inc. and University of Oxford (1.54)
    Regeneron Pharmaceuticals, Inc.1.34
    University of Oxford0.21
  5. Regeneron Pharmaceuticals, Inc. and University of Helsinki (1.51)
    Regeneron Pharmaceuticals, Inc.1.46
    University of Helsinki0.05
  6. Regeneron Pharmaceuticals, Inc. and National Autonomous University of Mexico (UNAM) (1.50)
    Regeneron Pharmaceuticals, Inc.1.39
    National Autonomous University of Mexico (UNAM)0.11
  7. Regeneron Pharmaceuticals, Inc. and Finland Ministry of Social Affairs and Health (1.49)
    Regeneron Pharmaceuticals, Inc.1.46
    Finland Ministry of Social Affairs and Health0.03
  8. Regeneron Pharmaceuticals, Inc. and The Hospital District of Helsinki and Uusimaa (HUS) (1.49)
    Regeneron Pharmaceuticals, Inc.1.46
    The Hospital District of Helsinki and Uusimaa (HUS)0.03
  9. Regeneron Pharmaceuticals, Inc. and VTT Technical Research Centre of Finland Ltd. (1.48)
    Regeneron Pharmaceuticals, Inc.1.46
    VTT Technical Research Centre of Finland Ltd.0.02
  10. Regeneron Pharmaceuticals, Inc. and European Molecular Biology Laboratory (EMBL) (1.48)
    Regeneron Pharmaceuticals, Inc.1.46
    European Molecular Biology Laboratory (EMBL)0.02